The American pharmaceutical company Pfizer exceeded expectations in the fourth quarter.
The company reported that its revenue amounted to $11.7 billion, resulting in a net profit of $594 million, or 10 cents per share. This surpassed the forecasts of analysts, who expected $10.6 billion in revenue and a net profit of $255 million.
"We were able to achieve strong results thanks to our diversified platform and strategic investments in innovation, which continue to provide us with long-term growth," said the CEO of Pfizer.
It is also worth noting that the company confirmed its financial forecasts for the current financial year, including the expected revenue in the range of $59.4-61.4 billion.
